Medication Assisted Treatment is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of opioid use disorder.
|Rule: Medication Assisted Therapy for Opioid Dependence||Any buprenorphine or methadone prescriber is responsible for complying with these rules.|
|Provider Clinical Support System||For consent documents as referenced in the MAT rule.|
|Opioid Treatment Screening Guidelines for Hubs||The primary goal of medication assisted therapy is to improve overall functioning of the patient. An important component of reaching this goal is the monitoring of illicit substance use. It is recommended that a comprehensive screening for drugs of abuse be done upon administration into opioid treatment programs.|
|Medication Assisted Treatment for Opioid Addiction||This medication assisted treatment fact sheet includes assessing the evidence, dosage and treatment limits, medication assisted treatment and pregnancy, and risks.|
|Vermont Guidelines for Medication Assisted Treatment for Pregnant Women||These guidelines were created to provide Vermont practitioners with recommendations for the management of opioid dependence during pregnancy.|
|Buprenorphine Billing Codes for Hubs||New HCPCS codes were issued in 2015 for Buprenorphine/Naloxone and Buprenorphine. The listed hub locations will be required to bill using these new codes effective 1/1/2017 in order to comply with proper billing practices. These new codes will need to replace the pre-existing code for Unclassified Drugs, J3490.|
|Opiate Care Alliance of Chittenden County - Consent to Disclose Form||Opiate Care Alliance of Chittenden County Attchment B: Consent to Disclosure of Health Information for Treatment and Coordination of Care|